LyH., KawaseY., YoneyamaR.et al.2007. Gene therapy in the treatment of heart failure. Physiology (Bethesda), 22:81–96.
2.
JessupM., GreenbergB., ManciniD.et al.2011. Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID): A phase 2 trial of intracoronary gene therapy of sarcoplasmic reticulum Ca2+-ATPase in patients with advanced heart failure. Circulation, 124:304–313.
3.
PlegerS.T., ShanC., KsienzykJ.et al.2011. Cardiac AAV9-S100A1 gene therapy rescues post-ischemic heart failure in a preclinical large animal model. Sci. Transl. Med., 3:92ra64.
4.
KhoC., LeeA., JeongD.et al.2011. SUMO1-dependent modulation of SERCA2a in heart failure. Nature, 477:601–605.
